High Beauty
French beauty retailer Sephora has announced
standards for CBD products as they add a fourth
line of topicals to stores across Europe and
America. These standards include complying to
the ‘clean Sephora’ rules which ban ingredients
such as parabens, mineral oils and possible toxins.
The CBD ingredients must be
from the US and must undergo
three rounds of testing for
quality and purity. The CBD
must be full or broad spectrum
only not isolate and they must
have a certifi cate of authenticity
which can be shown to
customers. Products on sale
include creams, serums, body
butters and mineral soaks.
Medical
cannabis
by post in
UK fi rst
UK medical cannabis
patients can now receive
their medicine without
stepping foot in a pharmacy.
Independent cannabis company
Shroom
for optimism?
The University of Miami has received
$1.624 million in funding from a
psychedelic research company to
explore whether CBD combined
with the active ingredient in ‘magic’
mushrooms can treat symptoms
of PTSD and mild traumatic brain
injury (mTBI). Up to 40% of people
with mTBI also suffer from PTSD. The
condition is even more common in
US military members.
FDA issues update on CBD
The US Food and Drug Administration has announced
new steps to protect market health and provide clarity
on CBD products. The agency is exploring potential
pathways for the regulation of products ranging from
edibles and teas to cosmetics and pet food.
It is continuing to take a proportionate approach to
EMMAC Life Sciences Group
has launched Medican, which
operates as a distance pharmacy,
allowing patients to submit their
prescriptions electronically to be
delivered by post.
Ed McDermott from EMMAC
UK said: “We believe our MHRA-
approved medical cannabis
manufacturing facility, combined
with our experienced team of
on-site pharmacists and health
care professionals will provide an
important service for the growing
number of patients requiring
medical cannabis.”
enforcement, targeting companies that are making
unfounded medical claims.
Speaking to the National Association of State
Departments of Agriculture, FDA commissioner, Dr
Stephen Hahn reassured brands and customers:
“We’re not going to be able to say, ‘You can’t use these
products.’ It’s a fool’s errand to even approach that.
But we want to get them the right information to
make the right decisions.”
15